Prevention of Inflammatory Bowel Diseases in Persons at Risk The PIONIR (Preventing IBD Onset in Individuals at Risk) Trial

NCT05211518 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2026-03-27

No results posted yet for this study

Summary

The goal of this study is to explore in a cross over randomized controlled trial, the ability of the Tasty\&Healthy dietary intervention (NCT04239248) to alter the parameters associated with future risk of developing Chron's disease (CD) using First Degree Relatives of patients with Crohn's disease, including subjects identified in the Genetic Environmental Microbiome (GEM) Study as having a high-risk score. Specifically, the investigators aim to determine if the Tasty\&Healthy dietary intervention can decrease the overall GEM Risk Score (GRS) and/or to alter the individual biological parameters that contribute to this score. The investigators hypothesize that the Tasty\&Healthy dietary approach will alter the risk of CD as reflected by a decrease in the GRS.

Conditions

  • Inflammatory Bowel Diseases

Interventions

OTHER

Tasty&Healthy

exclude pro-inflammatory dietary components

OTHER

Habitual diet

subjects will continue their habitual diet.

Sponsors & Collaborators

  • Samuel Lunenfeld Research Institute, Mount Sinai Hospital

    collaborator OTHER
  • The Hospital for Sick Children

    collaborator OTHER
  • The Governors of the University of Alberta

    collaborator UNKNOWN
  • University of Manitoba

    collaborator OTHER
  • IWK Health Centre

    collaborator OTHER
  • University of British Columbia

    collaborator OTHER
  • University of Calgary

    collaborator OTHER
  • McGill University

    collaborator OTHER
  • Beilinson Hospital, Petach Tikva,Israel

    collaborator UNKNOWN
  • Shaare Zedek Medical Center

    lead OTHER

Principal Investigators

  • Dan Turner, Prof · Saare Zedek Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
6 Years
Max Age
38 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-04
Primary Completion
2026-01-15
Completion
2026-01-15

Countries

  • Israel

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05211518 on ClinicalTrials.gov